Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Hiroaki, Hagihara"'
Autor:
Yuki Sasaki, Kazuyuki Matsumoto, Akinobu Takaki, Takuya Adachi, Masahiro Takahara, Keita Ozato, Yasuto Takeuchi, Masahiko Sue, Nozomi Miyake, Nozomu Wada, Hideki Onishi, Hidenori Shiraha, Takashi Oda, Koichiro Tsutsumi, Kazuhiro Nouso, Kazuya Kariyama, Hiroaki Hagihara, Akio Moriya, Motoyuki Otsuka
Publikováno v:
Gastro Hep Advances, Vol 3, Iss 8, Pp 1138-1147 (2024)
Background and Aims: Methods for predicting therapeutic response to immune checkpoint inhibitors in cancer therapy are in high demand. In patients with advanced hepatocellular carcinoma (HCC), atezolizumab (anti-programmed cell death-ligand 1 [PD-L1]
Externí odkaz:
https://doaj.org/article/5717d44ac54d405395840c4d75063afc
Autor:
Yasuto Takeuchi, Kazuhiro Nouso, Shin‐ichi Fujioka, Kazuya Kariyama, Haruhiko Kobashi, Shuji Uematsu, Akio Moriya, Hiroaki Hagihara, Hiroyuki Takabatake, Shinichiro Nakamura, Kazuhisa Yabushita, Tatsuya Kikuchi, Atsushi Oyama, Takuya Adachi, Nozomu Wada, Hideki Onishi, Hidenori Shiraha, Akinobu Takaki
Publikováno v:
Cancer Medicine, Vol 12, Iss 17, Pp 17559-17568 (2023)
Abstract Background and Aims The IMbrave 150 trial revealed the usefulness of atezolizumab plus bevacizumab therapy in patients with unresectable hepatocellular carcinoma (HCC), making it now considered the first‐line systemic chemotherapy agent fo
Externí odkaz:
https://doaj.org/article/1ea116a95b5e4f80b663222db653b559
Autor:
Kenji, Kuwaki, Kazuhiro, Nouso, Manabi, Miyashita, Yasuhiro, Makino, Hiroaki, Hagihara, Akio, Moriya, Takuya, Adachi, Nozomu, Wada, Yuki, Yasunaka, Tetsuya, Yasunaka, Yasuto, Takeuchi, Hideki, Onishi, Shinichiro, Nakamura, Fusao, Ikeda, Hidenori, Shiraha, Akinobu, Takaki, Hiroyuki, Okada
Publikováno v:
Acta Medica Okayama. 73(4):333-339
Steroids are often administered at the time of transcatheter arterial chemoembolization (TACE), a standard treatment of hepatocellular carcinoma (HCC), with the expectation of preventing postembolization syndrome. Here we investigated the precise eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::04a37d2cb8ecd365534b221eeae6d0c0
https://ousar.lib.okayama-u.ac.jp/56935
https://ousar.lib.okayama-u.ac.jp/56935
Autor:
Tatsuya Kikuchi, Yasuto Takeuchi, Kazuhiro Nouso, Kazuya Kariyama, Kenji Kuwaki, Junichi Toshimori, Shota Iwado, Akio Moriya, Hiroaki Hagihara, Hiroyuki Takabatake, Toshifumi Tada, Tetsuya Yasunaka, Masahiro Sakata, Masahiko Sue, Nozomi Miyake, Takuya Adachi, Nozomu Wada, Hideki Onishi, Hidenori Shiraha, Akinobu Takaki
Publikováno v:
Liver International; Jul2024, Vol. 44 Issue 7, p1736-1737, 2p
Autor:
Koichi Takaguchi, Hiroyuki Takabatake, Takuya Adachi, Hiroyuki Okada, Koji Miyahara, Shuji Uematsu, Tetsuya Yasunaka, Akinobu Takaki, Shouta Iwadou, Shinichi Fujioka, Fusao Ikeda, Kazuhiro Nouso, Chihiro Dohi, Hideki Onishi, Yoshitaka Takuma, Nozomu Wada, Haruhiko Kobashi, Hiroaki Hagihara, Atsushi Oyama, Hidenori Shiraha, Shinichiro Nakamura, Yasuto Takeuchi
Publikováno v:
Journal of Gastroenterology and Hepatology. 34:1081-1087
Background and aim Several factors, including proangiogenic cytokines, have been reported as predictive markers for the treatment effect of sorafenib in patients with hepatocellular carcinoma (HCC); however, most of them were determined based on one-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33e5ab175773749d2fa8955ff75cafa9
https://doi.org/10.1111/jgh.14535
https://doi.org/10.1111/jgh.14535
Autor:
Kazuhiro Nouso, Hideki Onishi, Toshihiko Kaneyoshi, Shouta Iwadou, Hideaki Taniguchi, Masaharu Ando, Kenta Motomura, Shinichi Fujioka, Akio Moriya, Haruhiko Kobashi, Masatoshi Tanaka, Yasuyuki Araki, Youichi Morimoto, Hiroyuki Okada, Hidenori Toyoda, Takashi Kumada, Shinichiro Nakamura, Kazuya Kariyama, Hiroaki Hagihara
Publikováno v:
Hepatoma Research. 2019
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa663deecb4a1794a3bf2c40a2c5ea72
https://doi.org/10.20517/2394-5079.2019.06
https://doi.org/10.20517/2394-5079.2019.06
Autor:
Shinichiro, Nakamura, Kazuhiro, Nouso, Yoshiyuki, Kobayashi, Hidenori, Shiraha, Hideki, Ohnishi, Junichi, Toshimori, Kenji, Kuwaki, Hiroaki, Hagihara, Hiroki, Takayama, Kazuhide, Yamamoto
Publikováno v:
Acta Medica Okayama. 67(4):239-244
The aim of this study was to evaluate the histologic diagnosis of hypovascular hepatic lesions showing hypointensity on hepatobiliary phase images of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced MRI (EOB-MRI). In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::a400d98a2572da11e0c0363672a01386
https://ousar.lib.okayama-u.ac.jp/51068
https://ousar.lib.okayama-u.ac.jp/51068
Autor:
Kenji Kuwaki, Kazuhide Yamamoto, Hideaki Kinugasa, Hidenori Shiraha, Takeshi Tomoda, Shinichiro Nakamura, Junki Toyosawa, Kazuhiro Nouso, Akinobu Takaki, Yasuhiro Miyake, Fusao Ikeda, Koji Miyahara, Hiroaki Hagihara, Sayo Kobayashi, Hideki Onishi
Publikováno v:
Journal of Gastroenterology and Hepatology. 28:1391-1396
Background and aim Follistatin (FST) is a glycoprotein expressed in most organs, which interacts with activins or other members of the transforming growth factor beta family. Recently, several reports have shown that FST regulates a variety of proces
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26846f2ce32ff256c5ea66e3a9681606
https://doi.org/10.1111/jgh.12167
https://doi.org/10.1111/jgh.12167
Autor:
Yasuhiro Miyake, Yoshiyuki Kobayashi, Hidenori Shiraha, Yuki Morimoto, Yoshitaka Takuma, Shinichiro Nakamura, Hiroyuki Takabatake, Fusao Ikeda, Koichi Takaguchi, Kenji Kuwaki, Akinobu Takaki, Kazuhide Yamamoto, Kazuhiro Nouso, Kohsaku Sakaguchi, Koji Miyahara, Yasuto Takeuchi, Shouta Iwadou, Hideki Onishi, Hiroaki Hagihara
Publikováno v:
Hepatology Research. 44:296-301
Aim We investigated whether continuous sorafenib administration keeps suppressing the growth of hepatocellular carcinoma (HCC) after first progressive disease (PD), and whether it prolongs patients' survival. Methods The size of metastatic lesions wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::92cd45492321cd8cef0f4a625f186dc8
https://doi.org/10.1111/hepr.12123
https://doi.org/10.1111/hepr.12123
Autor:
Shin-Ichiro Nishimura, Koichiro Tsutsumi, Naoki Yamamoto, Akinobu Takaki, Hideki Onishi, Maho Amano, Takeshi Tomoda, Koji Miyahara, Kazuhiro Nouso, Sayo Kobayashi, Fusao Ikeda, Hidenori Shiraha, Hironari Kato, Yoichi M. Ito, Shinichiro Nakamura, Kenji Kuwaki, Kazuhide Yamamoto, Yuki Morimoto, Taku Nakahara, Hiroaki Hagihara, Yasuhiro Miyake
Publikováno v:
Journal of Gastroenterology. 48:1171-1179
Most of the glycan changes reported in cancers were based on the examinations of a small number of patients or particular proteins. The aim of this study was to determine the changes of the serum N-glycan profile comprehensively in a large number of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03bb44e1559b0f0565aae379ba9940c7
https://doi.org/10.1007/s00535-012-0732-7
https://doi.org/10.1007/s00535-012-0732-7